Mission

We will not make progress without clinical trials. It is wrong and unfair to deny patients access to clinical trials.

Richard Klausner, MD

The ability of doctors to deliver the newest therapies to patients is a critical component of medical research. We strive to promote access to clinical trials for patients who might otherwise not be offered the option.

The Team

Dr. Rocco J Crescenzo

Dr. Crescenzo earned his degree from the Philadelphia College of Osteopathic Medicine. He went on to complete a residency in internal medicine at Graduate Health System - PCOM and a fellowship in haematology/medical oncology at Thomas Jefferson University.

After completing his training he held academic positions at Hahnemann-MCP, PCOM, and Temple University.

In 2007, he joined the pharmaceutical industry. He worked at GSK for 7 years, where he held various positions of increasing responsibility. After GSK he worked at Novartis and Pfizer.

In 2019 Dr. Crescenzo decided to start his own business assisting health care institutions and smaller biotech companies in developing a clinical trial program for diagnostics and drug development.

Linda Haffelfinger, PA-C

Linda has over 20 yrs of experience in clinical trials and patient care. She has participated in and help run multiple programs in the community setting.

Trident approach

Pharma/biotech

Health Care Systems

Hunter can serve as a partner in developing and running clinical trials.

We can do as much or as little as required by our clients.

Health Care Systems

Hunter is very interested in helping medium sized healthcare systems develop and run clinical trial programs.

We maintain the infrastructure, assist in acquiring clinical trials, run the clinical trials, and help promote the hospital system in the community as one of the regional leaders in cutting-edge patient care.

The goal of such activities is to bring state of the art care to the community setting.

Real World Data

Health Care Systems

Real World Data

Pharmaceutical companies are desperate to get real world data incorporated into their clinical trials.

Hunter will work with the health-care systems to link up pharmaceutical companies with the most appropriate community partner.

Thereby, maximising real world data, patient access, and academic collaboration.